PGx News

We are happy to announce that Sara Van Driest, M.D., Ph.D. was selected by the National Institutes of Health’s All of Us Research Program to serve as the program’s first director of pediatrics.

In this position, she will help set the foundation for how people under the age of 18 can participate in this landmark precision medicine effort.

Dr. Van Driest is a PGRN member and the Secretary of Council. Her research has focused on improving the dosing and understanding the effects of commonly used medications, including antibiotics, analgesics, and sedatives in children. Among her many roles, she serves on the steering committee for the Clinical Pharmacogenetics Implementation Consortium and on the scientific advisory boards for PharmVar, a central repository for pharmacogenomic variation, and PharmCAT, a freely available pharmacogenomics clinical annotation tool.

Dear PGRN members,

Please join me in congratulating the following colleagues on receiving two prestigious awards from the American Society of Clinical Pharmacology and Therapeutics:

Dr. Julie Johnson: ASCPT Mentor Award

Dr. Jasmine Luzum: Leon I. Goldberg Early Investigator Award

They are a point of pride for PGRN, and we look forward to their continuing success in pharmacogenomics and clinical pharmacology broadly.

Best regards,

Jun J. Yang

President, PGRN

Endowed Chair in Pharmacogenomics
St. Jude Children's Research Hospital

PGRN founding member Aniwaa Owusu Obeng, PharmD, is currently leading a PGx CME series hosted by the Mount Sinai Medical System, titled "The Clinician's Guide to Personalized Theraputics." Live zoom sessions started in late 2021 and will continue through September of 2022.

PGRN members can find more information or register using the links below.

More Details

Register Now 

The mission of the PGRN Research Collaborative Grant is to foster collaboration among PGRN members to advance the science of pharmacogenomics as it relates to all aspects of precision medicine. Grants up to $20,000 will be awarded on a competitive basis to PGRN members who enter into collaborative arrangements, including with other academic researchers or industry partners. Proposals that include international collaboration and participants from diverse and understudied populations will be prioritized.

For more information

ASCPT announced the 2022 ASCPT Award recipients who will be formally recognized during the 2022 virtual Annual Meeting. The ASCPT Awards have a rich history of recognizing excellence in the fields of clinical pharmacology and translational science. The 2022 recipients demonstrate devotion that drives innovation and achievement for the benefit of patients and society.

We are proud to announce that two PGRN members will be receiving prestigious ASCPT Awards. Please take a moment to congratulate them for their achievements.

Rawls-Palmer Progress in Medicine Award
Deanna Kroetz, PhD, University of California San Francisco

ASCPT Mentor Award
Hendrik Jan Guchelaar, PharmD, PhD, Leiden University

On behalf of Matthias Schwab and myself, I am writing to cordially invite you to submit your work to Pharmacogenetics and Genomics. Established in 1991, the Journal is devoted to disseminating research discoveries related to pharmacogenomics and precision medicine. We strive to rapidly evaluate and publish high-quality work elucidating genetic determinants of drug response, ranging from genomic discovery to mechanistic studies, pre-clinical modeling, and clinical implementation.  

As we celebrate the 30th Anniversary of the Journal this year and with the guidance of our editorial board (https://journals.lww.com/jpharmacogenetics/Pages/editorial board.aspx), we are committed to becoming the flagship publication platform in the field of pharmacogenomics. For this reason, we particularly value the impact of PGRN and sincerely call on PGRN members to consider Pharmacogenetics and Genomics for your next manuscript (https://www.editorialmanager.com/pgen/). We also welcome volunteer reviewers; please email our editorial coordinator, Prachi Deshpande (prachi.deshpande@wolterskluwer.com) if you are interested. 

Share your work and shape the future of pharmacogenomics!

Jun J. Yang PhD and Matthias Schwab MD

Chief Editors

https://journals.lww.com/jpharmacogenetics/Pages/currenttoc.aspx

Pharmacogenetic Testing in Healthy Individuals
Due: Oct 10, 2021
Contact: daria.dou@mdpi.com

Information: https://www.mdpi.com/journal/jpm/special_issues/pharmacogenetic_individuals

Pharmacogenetics of Treating Anxiety & Depression

Due Date: March 31, 2022
Contact: Laura.ramsey@cchmc.org

https://www.mdpi.com/journal/jpm/special_issues/Pharmacogenetics_Anxiety 

Initiative to Maximize Research Education in Genomics:  Diversity Action Plan (R25)
(PAR-16-345): https://grants.nih.gov/grants/guide/pa-files/PAR-19-380.html

Advancing Genomic Medicine Research (R21 Clinical Trial Optional) (RFA-HG-20-037)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-20-037.html